Clinical trials in Berlin – page 77

1 770 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Berlin at a glance

1 770

clinical trials

Research sites17

Quick filters

1 770 trials in Berlin

Open in trial search

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

Investigational

Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Resmetirom
Sponsor:Madrigal Pharmaceuticals Inc.

Contact Research Centre

Asthmatic crisis

Not recruiting

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Investigational

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
Sponsor:Upstream Bio Inc.

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Janssen Cilag International

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anifrolumab
Sponsor:AstraZeneca AB

Contact Research Centre

Psoriasis

Not recruiting

Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

Investigational

Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Jnj-81241459
Sponsor:Janssen Cilag International

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Duvakitug
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Quinidine Sulfate
Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Isis 678354 Sodium Salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Parkinson's disease

Not recruiting

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tavapadon
Sponsor:Cerevel Therapeutics LLC

Contact Research Centre

Schizophrenia

Not recruiting

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Germany

Participants:18–64 years
Substances:Iclepertin
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Systemic scleroderma

Not recruiting

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational

Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Fipaxalparant
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Berlin

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.

Prostate Cancer Therapeutics
Colorectal Cancer Treatment
Early-Stage Breast Cancer
Bladder Cancer Interventions

Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.

02 Infectious Disease Prevention

Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.

RSV Vaccine Development
CMV Prevention
Yellow Fever Protection
Herpes Virus Management

These trials aim to enhance immune response and provide long-term protection against serious viral infections.

03 Chronic Conditions

Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.

Neurological Disorders
Metabolic Conditions
Organ Transplantation
Women's Health

Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.

Back to Germany All countries